Metabolic Research Peptides

The metabolic category is the deepest in our catalogue, spanning the incretin era's flagship compounds and the somatotropic-axis peptides that preceded them. On the incretin side: semaglutide (GLP-1 receptor agonist), tirzepatide (dual GIP/GLP-1) and retatrutide (triple GIP/GLP-1/glucagon), plus the long-acting amylin analogue cagrilintide — the four molecules defining modern energy-balance research.

On the growth-hormone axis: sermorelin, the benchmark GHRH(1-29) fragment; CJC-1295 without DAC (Modified GRF 1-29); tesamorelin, the GHRH analogue with the deepest clinical evidence base; and ipamorelin, the selective ghrelin-receptor secretagogue — studied alone and in the classic CJC/ipamorelin combination for pulsatile GH release. The category also includes 5-Amino-1MQ, a small-molecule NNMT inhibitor studied for NAD+-linked adipocyte metabolism, and AOD-9604, the lipolytic hGH fragment.

Every product page carries per-batch purity data, spec tables with cost-per-milligram, and plain-English summaries of the key studies. For research use only — not for human or veterinary use.